AMNAMN Healthcare Services, Inc.
AMN Healthcare Services, Inc. (AMN) provides IT services and healthcare staffing solutions, with a focus on clinical and administrative support for healthcare providers. The next catalyst is Nov 6, 2026 — Q3 2026 Earnings Release, which will test the company’s ability to stabilize its core nursing business and deliver on its rebranding and partnership momentum.
- Revenue fell 8.5% YoY to $3.34B in the second quarter of 2026, with net income at -$3.59M and a net margin of -0.1%.
- The company has a debt-to-equity ratio of 1.19x and a diluted EPS of $0.53, reflecting ongoing pressure on profitability.
- AMN’s recent partnership with Brightfield to enhance workforce intelligence could signal a shift toward data-driven healthcare solutions.
The Read
1% on Q4 2025 earnings that beat estimates and signaled stabilization in its core nursing business, but then mixed on Q2 2026 results with limited directional clarity despite rebranding and partnerships.
The schedule
- Fri6Nov
This earnings report will test the company's ability to meet expectations in a volatile market environment, with a focus on revenue growth and cost management. The outcome will be critical for assessing the company's operational performance and its ability to navigate macroeconomic headwinds.
- Tue9Feb
This report will assess the company's ability to sustain momentum from the Q3 earnings and deliver on its guidance. The outcome will be key for evaluating its long-term growth prospects and financial discipline.
- Tue11May
- Fri6Aug
This report will evaluate the company's performance over the past year and its ability to meet long-term strategic goals. The outcome will be crucial for assessing its financial health and growth trajectory.
Past
- Fri7Aug
Actual outcome: Bear · $34.49 at outcome
AMN reported Q2 earnings with revenue of $673 million and adjusted EPS of $0.77, slightly above expectations. However, the stock fell 4.4% as investors reacted to weaker-than-expected GAAP income of $0.53/share and concerns over margin pressure and deceleration in growth, which triggered a move toward the bear floor.
AMN will report Q2 earnings facing significant 'sell-the-news' risk. A strong beat could push shares to $37.50, but any signs of deceleration could trigger a drop to $30.00.
- Thu19Feb
Actual outcome: Bull · $20.40 at outcome
AMN reported Q4 revenue of $748 million, beating estimates, and provided robust Q1 2026 guidance forecasting up to 80% revenue growth, which signaled the long-awaited stabilization in the core nursing business. This outlook, combined with core demand exceeding guidance midpoints even when excluding temporary labor disruptions, triggered an 18.1% rally and an analyst upgrade to a $24.00 price target.
